<DOC>
	<DOCNO>NCT01178905</DOCNO>
	<brief_summary>To evaluate , prospective multicenter study , ultrashort-term heat inactivation prevention Cytomegalovirus ( CMV ) transmission preterm infant ( &lt; 32 week gestational age &lt; 1500 g birth weight ) clinical condition . Inactivation do period infectivity breast milk , characterized viral excretion strongly associate subsequent infection , monitor periodic virologic examination BM urine infant . Thus investigator hypothesis CMV transmission breast milk occur use gentle ultrashort heat inactivation procedure apply infective breast milk . The protocol approve ethic committee Tuebingen University Hospital .</brief_summary>
	<brief_title>Clinical Evaluation Ultrashort-term Heat Inactivation Cytomegalovirus ( CMV ) Containing Raw Breast Milk Prevent CMV-infection Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<criteria>&lt; 32 Weeks GA &lt; 1500g BW mother CMV IgG positive breast milk feed parent disagree</criteria>
	<gender>All</gender>
	<minimum_age>23 Weeks</minimum_age>
	<maximum_age>40 Weeks</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Postnatal CMV infection preterm infant</keyword>
	<keyword>breast milk</keyword>
</DOC>